Analgesic effect of melatonin in association with ondansetron, petidine and tramadol in a murine model of behavior

Acta Endocrinologica

Volumn 6, Issue 2, 2010, Pages 143-150

  Arsene, A ^a   Cristea, A ^a   Mitrea, N ^a   Negres, S ^a  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Analgesic effect; Biologic variability; Melatonin; Psychoneuroendocrine typology

Indexed keywords

EID: 79960394955     PISSN: 18410987     EISSN: None     Source Type: Journal    
DOI: 10.4183/aeb.2010.143     Document Type: Article

References (19)

1. Bothorel B, Barassin S, Saboureau M, Perreau S. In the rat, exogenous melatonin increases the amplitude of pineal melatonin secretion by a direct action on the circadian clock. Eur J Neurosci 2002; 16:1090-1098.
2. Simonneaux V., Ribelayga C. Generation of the Melatonin Endocrine Message in Mammals:A Review of the Complex Regulation of Melatonin Synthesis by Norepinephrine, Peptides, and Other Pineal Transmitters. Pharmacol Rev. 2003; 55: 325-395.
3. Ganguly S, Coon SL, Klein DC. Control of melatonin synthesis in the Mammalian pineal gland: the critical role of serotonin acetylation. Cell Tissue Res 2002; 309: 127-137.
4. Garidou ML, Diaz E, Calgari C. Transcription factors may frame Aa-nat gene expression and melatonin synthesis at night in the Syrian hamster pineal gland. Endocrinology 2003; 144: 2461-2472.
5. Garidou ML, Vivien Roels B, Pevet P. Mechanism regulating the marked seasonal variation in melatonin synthesis in the European hamster pineal gland. Am J Physiol Regul Integr Comp Physiol 2003; 284: R1043-R1052.
6. Friedman M, Rosenman RH. Association of specific behavior pattern with blood and cardiovascular findings. JAMA. 1959;169: 1286-1296.
7. Friedman M, Rosenman RH. Overt behavior pattern in coronary disease: detection of overt behavior pattern A in patients with coronary disease by a new psychophysiological procedure. JAMA 1960;173: 1320-1326.
8. Appleton KM, Woodside J, Yarnell JWG. Type A behavior and consumption of atherogenic diet: No association in the PRIME study. Appetite 2007; 46:378-386.
9. Cristea A. Mechanisms of stress analgesia in opioid and adrenergic types of behavior. European Neuropsychopharmacology; 1994: 4, 427-428.
10. Cristea A. Opioid and adrenergic type of behavior to stress. European Neuropsychopharmacology; 1993:3, 446-447.
11. Cristea A, Moldovan M, Munteanu A-M, Popa DP, Negres S, Zãgrean L. EEG differences between the opioid and adrenergic psychoneuroendocrine rat types. Rom. J. Physiol.; 1998: 35(1-2) 153-159.
12. Cristea A, Negres S, Morteanu E. The reaction to convulsive stimulus of the opioid and adrenergic psychoneuroendocrine mice types. Rom. J. Neurol.; 1999: 37 (1-2), 95-103.
13. Cristea A, Negres S, Turculet L, Pastaie M. Cercetãri farmacologice experimentale privind reactivitatea tipului opioid, comparativ cu tipul adrenergic, la medicamentele analgezice opioide, în testul stimulului termic (hot-plate).Farmacia 2005: 1, 16-21.
14. Cristea A, Stefãnescu A-M, Ciobanu A. Catecholamine levels in opioid and adrenergic psychoneuroendocrine types. Rom. J. Endocrin.; 1996: 1-4, 95-101.
15. Arsene A, Aramã C, Mitrea N, Cristea AN. Experimental assessment of cerebral monoaminergic status in a murine model of behavior. Farmacia 2009; 4: 3-9.
16. Arsene A, Cristea A, Gradinaru D, Mitrea N. Experimental research regarding the monoaminoxidase activity in acute stress, in the pschychoneuroendocrine behavioral adrenergic and opioid types Farmacia 2006; 3: 3-9.
17. Nitulescu-Arsene A.L, Mitrea N, Cristea A, Drãgoi C.M Experimental research on mice regarding the implication of melatonin in pain management, Farmacia 2009; 57:223-228.
18. Diaz E, Garidou ML, Dardente H. Expression and regulation of mRNA in the Syrian hamster pineal gland. Brain Res Mol Brein Res 2003; 122: 163-169.
19. Fuchs PN, Meyer RA, Raja SN. Heat, but not mechanical, hyperalgesia following adrenergic injections in normal human skin. Pain 2001;90:15-23.